Lepu Biopharma Co., Ltd.
Lepu Biopharma Co., Ltd. (HKSE: 2157) is trading at HK$3.80, about ₹46 at today's HKD/INR rate, as of 25 Sep 2026, 4:08 AM ET, up 0.13% today. Indian residents can buy Lepu Biopharma from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$3.68
Today's high
HK$3.83
52 week low
HK$3.55
52 week high
HK$8.11
2157 opened at HK$3.82, closed previously at HK$3.79, and has traded between HK$3.55 and HK$8.11 over the past 52 weeks.
About
Lepu Biopharma Co., Ltd. operates as a biopharmaceutical enterprise, concentrating its efforts on the development of innovative oncology therapies. It maintains a broad pipeline of cancer-fighting products primarily aimed at the Chinese market. The company's therapeutic candidates encompass a range of modalities, including cutting-edge antibody-drug conjugates (ADCs), oncolytic virus treatments, and diverse immunotherapies. Among its immuno-oncology offerings are HX008 (an anti-PD-1 mAb) and LP002 (an anti-PD-L1 mAb). The ADC portfolio features MRG003 (targeting EGFR), MRG002 (targeting HER2), MRG001 (targeting CD20), MRG004A (targeting TF), and CMG901 (targeting CLDN18.2). Additionally, Lepu Biopharma is advancing the oncolytic virus CG0070, along with various combination therapies such as HX008+OH2, LP002+OH2, and HX008+LP002. Founded in 2018, the company is headquartered in Shanghai, China.
Key statistics
Avg. volume
9.95M
Market cap
HK$6.85B
P/E Ratio
24.06
Price-to-sales ratio
6.00
Enterprise value
CN¥6.36B
Free cash flow yield
-4.41%
Debt-to-equity ratio
0.84
Return on equity
17.36%
ROIC
2.35%
Beta
-0.42
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
CN¥910.67M
Earnings per share
CN¥0.14
Free cash flow
-CN¥82.80M
Net profit margin
24.89%
Gross margin
79.09%
EBITDA
CN¥178.73M
Revenue growth
147.60%
Similar securities
This is not an investment recommendation
How to buy Lepu Biopharma from India
Indian residents can buy Lepu Biopharma shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Lepu Biopharma and place an order
Find Lepu Biopharma by name or by its ticker, 2157, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Lepu Biopharma trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Lepu Biopharma position in HKD and INR. Lepu Biopharma pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Lepu Biopharma from India
Trading and taxes when buying Lepu Biopharma from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneLepu Biopharma does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Lepu Biopharma stock?
Yes. Lepu Biopharma (2157) has been listed on the Hong Kong Stock Exchange since 2022, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Lepu Biopharma share cost in rupees?
One Lepu Biopharma share is HK$3.80 — about ₹46 at an HKD/INR rate of 12.25 on 24 Sep 2026. Both the Lepu Biopharma price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Lepu Biopharma from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Lepu Biopharma?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Lepu Biopharma shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Lepu Biopharma price. Paasa issues a capital-gains statement for your return.
Does Lepu Biopharma pay a dividend?
No. Lepu Biopharma does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Lepu Biopharma from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Lepu Biopharma a Hong Kong SAR China company, and does that change how it is taxed?
Lepu Biopharma trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Lepu Biopharma trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Lepu Biopharma shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Lepu Biopharma holding, its cost and its closing value.
How do I sell Lepu Biopharma and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.